Nawras Makhsida, M.D.
Endocrinology, Diabetes & Metabolism Physician · Randolph, NJ
Nawras Makhsida, M.D. is an endocrinology, diabetes & metabolism physician with a practice address in Randolph, New Jersey, and NPI 1154523959, issued on Jun 4, 2007. Check the license (New Jersey 25MA11801900, as entered in NPPES) on the New Jersey State Board of Medical Examiners; the Medicare figures below come from public CMS files.
- Name
- Nawras Makhsida
- Credential
- M.D.
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License number
- 25MA11801900 NJ
Self-reported in NPPES; status is on the state search - Practice location
- 715 Route 10, Randolph, NJ 07869
- Phone
- (973) 343-7040
- Enumerated
- Jun 4, 2007
- Record last updated
- Nov 3, 2023
- Fax
- (973) 718-4881
- Medicaid ID
- 0943592 NJ
- Medicare enrollment
- Enrolled (PECOS I20230628002935); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest endocrinology, diabetes & metabolism physician records → All 417 in New Jersey → Look up another NPI →
Verify Nawras Makhsida in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNew Jersey State Board of Medical Examiners
Search for license 25MA11801900Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
42% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
1,528 Medicare Part D claims for 280 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 66% of claims.
Most prescribed
- Mounjaro288 claims
- Jardiance134 claims
- Levothyroxine Sodium119 claims
- Soliqua 100-33104 claims
- Ozempic93 claims
- Alendronate Sodium91 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $58,143.16
175 payments; by number, the most common kind was food and beverage; the largest payer was Lilly USA, LLC. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Premier Health Associates LLCNewton, NJ
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Nawras Makhsida among 417 endocrinology, diabetes & metabolism physician records in New Jersey
Nawras Makhsida, M.D. is one of 417 endocrinology, diabetes & metabolism physician records with a practice address in New Jersey. 85% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 39% of them.
- NPI issued2007 · 39% of these records are older, 50% newer
- In a Medicare fileYes · 85% of these records are
- In the CMS Doctors and Clinicians fileYes · 75% of these records are
- Graduated2003 · median 2006 among the 313 with a school on file
- Record last updated2023 · 56% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a New Jersey practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in New Jersey
There are 417 endocrinology, diabetes & metabolism physician records in New Jersey.
All 417 in New Jersey → Every provider in Randolph → Endocrinology, Diabetes & Metabolism Physician nationwide →
The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes
- Javier Duron Tabora, MDSparta, NJ 078711356861496
- Sameer Stas, M.D.Newton, NJ 078601871541185
- James Chen, M.D.Summit, NJ 079011427092626
- Bhanu Iyer, MDSummit, NJ 079011730287269
- Sharon Selinger, M.D.Summit, NJ 079011447337415
- Aristea Sideri Gugger, M.D., PH.D.Summit, NJ 079011235661299
- Javier Torrens, MDSummit, NJ 079011578555298
- Murray LasDenville, NJ 078341114003928
Common questions
What is Nawras Makhsida, M.D.'s NPI number?
Nawras Makhsida, M.D.'s National Provider Identifier (NPI) is 1154523959, issued on Jun 4, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Nawras Makhsida, M.D. located?
The NPPES record lists a practice address at 715 Route 10, Randolph, NJ, 07869. Phone: (973) 343-7040. Providers update this record themselves, so call before visiting.
How can I verify Nawras Makhsida, M.D.'s license?
NPPES lists New Jersey license number 25MA11801900, as entered by the provider. Search the New Jersey State Board of Medical Examiners at https://newjersey.mylicense.com/verification/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Nawras Makhsida, M.D. prescribe under Medicare Part D?
In 2024, Nawras Makhsida, M.D. had 1,528 Medicare Part D claims for 280 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.